• Je něco špatně v tomto záznamu ?

Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance

Z. Heger, MA. Rodrigo, S. Krizkova, B. Ruttkay-Nedecky, M. Zalewska, EM. Del Pozo, A. Pelfrene, B. Pourrut, M. Stiborova, T. Eckschlager, G. Emri, R. Kizek, V. Adam,

. 2016 ; 17 (12) : 1438-51.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031896

Cardiotoxicity is a serious complication of anticancer therapy by anthracycline antibiotics. Except for intercalation into DNA/RNA structure, inhibition of DNA-topoisomerase and histone eviction from chromatin, the main mechanism of their action is iron-mediated formation of various forms of free radicals, which leads to irreversible damage to cancer cells. The most serious adverse effect of anthracyclines is, thus, cardiomyopathy leading to congestive heart failure, which is caused by the same mechanisms. Here, we briefly summarize the basic types of free radicals formed by anthracyclines and the main processes how to scavenge them. From these, the main attention is paid to metallothioneins. These low-molecular cysteine-rich proteins are introduced and their functions and properties are reviewed. Further, their role in detoxification of metals and drugs is discussed. Based on these beneficial roles, their use as a new therapeutic agent against oxidative stress and for cardioprotection is critically evaluated with respect to their ability to increase chemoresistance against some types of commonly used cytostatics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031896
003      
CZ-PrNML
005      
20171122122734.0
007      
ta
008      
171025s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1389450116666151001113304 $2 doi
035    __
$a (PubMed)26424389
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Heger, Zbynek
245    10
$a Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance / $c Z. Heger, MA. Rodrigo, S. Krizkova, B. Ruttkay-Nedecky, M. Zalewska, EM. Del Pozo, A. Pelfrene, B. Pourrut, M. Stiborova, T. Eckschlager, G. Emri, R. Kizek, V. Adam,
520    9_
$a Cardiotoxicity is a serious complication of anticancer therapy by anthracycline antibiotics. Except for intercalation into DNA/RNA structure, inhibition of DNA-topoisomerase and histone eviction from chromatin, the main mechanism of their action is iron-mediated formation of various forms of free radicals, which leads to irreversible damage to cancer cells. The most serious adverse effect of anthracyclines is, thus, cardiomyopathy leading to congestive heart failure, which is caused by the same mechanisms. Here, we briefly summarize the basic types of free radicals formed by anthracyclines and the main processes how to scavenge them. From these, the main attention is paid to metallothioneins. These low-molecular cysteine-rich proteins are introduced and their functions and properties are reviewed. Further, their role in detoxification of metals and drugs is discussed. Based on these beneficial roles, their use as a new therapeutic agent against oxidative stress and for cardioprotection is critically evaluated with respect to their ability to increase chemoresistance against some types of commonly used cytostatics.
650    _2
$a zvířata $7 D000818
650    _2
$a antracykliny $x aplikace a dávkování $x škodlivé účinky $7 D018943
650    _2
$a protinádorová antibiotika $x aplikace a dávkování $x škodlivé účinky $7 D000903
650    _2
$a kardiomyopatie $x etiologie $x prevence a kontrola $7 D009202
650    _2
$a kardiotonika $x farmakologie $7 D002316
650    _2
$a chemorezistence $7 D019008
650    _2
$a scavengery volných radikálů $x farmakologie $7 D016166
650    _2
$a volné radikály $x metabolismus $7 D005609
650    _2
$a srdeční selhání $x chemicky indukované $x prevence a kontrola $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a metalothionein $x metabolismus $x farmakologie $7 D008668
650    _2
$a nádory $x farmakoterapie $x patologie $7 D009369
650    _2
$a oxidační stres $x účinky léků $7 D018384
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rodrigo, Miguel Angel Merlos
700    1_
$a Krizkova, Sona
700    1_
$a Ruttkay-Nedecky, Branislav
700    1_
$a Zalewska, Marta
700    1_
$a Del Pozo, Elena Maria Planells
700    1_
$a Pelfrene, Aurelie
700    1_
$a Pourrut, Bertrand
700    1_
$a Stiborova, Marie
700    1_
$a Eckschlager, Tomas
700    1_
$a Emri, Gabriella
700    1_
$a Kizek, Rene
700    1_
$a Adam, Vojtěch $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. vojtech.adam@mendelu.cz. $7 xx0064599
773    0_
$w MED00007902 $t Current drug targets $x 1873-5592 $g Roč. 17, č. 12 (2016), s. 1438-51
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26424389 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171122122854 $b ABA008
999    __
$a ok $b bmc $g 1255489 $s 992923
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 17 $c 12 $d 1438-51 $i 1873-5592 $m Current drug targets $n Curr Drug Targets $x MED00007902
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...